Cargando…
Growth Hormone Therapy in Adults with Prader-Willi Syndrome
Prader-Willi syndrome (PWS) is characterized by hyperphagia, obesity if food intake is not strictly controlled, abnormal body composition with decreased lean body mass and increased fat mass, decreased basal metabolic rate, short stature, low muscle tone, cognitive disability, and hypogonadism. In a...
Autores principales: | Vogt, Karen S., Emerick, Jill E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548233/ https://www.ncbi.nlm.nih.gov/pubmed/28943608 http://dx.doi.org/10.3390/diseases3020056 |
Ejemplares similares
-
Endocrine manifestations and management of Prader-Willi syndrome
por: Emerick, Jill E, et al.
Publicado: (2013) -
Prader-Willi Syndrome and Growth Hormone Deficiency
por: Aycan, Zehra, et al.
Publicado: (2014) -
Growth hormone therapy for Prader–willi syndrome: challenges and solutions
por: Grugni, Graziano, et al.
Publicado: (2016) -
Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis
por: Rosenberg, Anna G W, et al.
Publicado: (2021) -
Growth hormone treatment for adults with Prader-Willi syndrome: another point of view
por: Hirsch, Harry J., et al.
Publicado: (2021)